Premier Alternatives

Juvenescence

Dublin, Ireland · Founded 2016 · Privately Held (backing)

Developer of an anti-aging therapeutics designed to extend healthy lifespan by targeting core aging mechanisms. Juvenescence is based in Dublin, Ireland and was founded in 2016. Its last reported valuation was $502 million in Aug 2019. It has raised $341 million across 4 recorded rounds; the latest was a $9.4 million early-stage round in Dec 2020.

Last reported valuation
$502.0M
Oct 2026
Priced at
—
Total raised
$340.7M
Last round
Early Stage VC
Dec 2020

Juvenescence key facts

as of Oct 2026
  • Developer of an anti-aging therapeutics designed to extend healthy lifespan by targeting core aging mechanisms.
  • Juvenescence is valued at approximately $502.0M as of Oct 2026 (last reported valuation).
  • It has raised $340.7M across 4 recorded rounds; the latest was Early Stage VC ($9.4M) in Dec 2020.
  • Notable investors include Foresite Capital, London Technology Club, GG 1978, Grok Ventures, IDO Investments — 18 tracked in total.
  • Juvenescence has filed 6 Form Ds with the SEC since 2017, most recently Jun 2021 ($9.4M sold to 15 investors).
  • Status: Privately Held (backing).
Last reported valuation
LOW confidence
$502.0M

Juvenescence's last reported valuation, Aug 2019. Nothing priced has surfaced since.

set by last reported valuationas of Oct 2026question about this number?
Free account
More of Juvenescence with a free account
  • ·The complete investor list: 18 names
  • ·Watch Juvenescence: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Juvenescence funding rounds

4 rounds
Dec 2020Early Stage VC$9.4MSEC filing▮
Apr 2019Later Stage VC$56.9MSEC filing▮
Jun 2018Later Stage VC$53.1MSEC filing▮
Dec 2017Seed Round$2.5MSEC filing▮
Full funding history →

Juvenescence valuation

Juvenescence's last reported valuation was $502 million in Aug 2019. No priced round, secondary trade or fund mark has surfaced since.

How much has Juvenescence raised?

Juvenescence has raised $341 million in total; 4 of its rounds are on record, from 2017 on. The largest on record was a $9.4 million early-stage round in Dec 2020.

Juvenescence has filed 6 Form Ds with the SEC since 2017, most recently in Jun 2021 ($9.4 million sold to 15 investors).

Juvenescence investors

18 investors are on record for Juvenescence, including Foresite Capital, London Technology Club, GG 1978 and Grok Ventures. By type, the record holds 3 venture capital firms and 2 family offices. The early-stage round in Dec 2020 drew 15 investors.

About Juvenescence

Developer of an anti-aging therapeutics designed to extend healthy lifespan by targeting core aging mechanisms. The company leverages artificial intelligence to develop a pipeline of clinical and near-clinical stage candidates for cognition, cardio-metabolism, immunity, and cellular repair, enabling medical companies with the treatment and prevention of age-related diseases while supporting advancements in regenerative medicine.

Sector
Healthcare
HQ
Dublin, Ireland
Founded
2016
Employees
38
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.